RxDoctor Payments Data

Mostafa Abousayed, MD

Foot and Ankle Surgery · North Easton, MANPI 1447679428

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (41.4%), education and food and beverage — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Kairos Surgical Inc at 39.6% of the total. Reporting peaked in 2024 at $3,894 and has fallen 84.3% since, to $613 in 2025. Among foot and ankle surgery clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,634in general payments, 2019–2025

Across 99 payments — averaging $127.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kairos Surgical Inc$5K
  • Stryker$3K
  • Restor3d, Inc.$1K
  • Paragon 28, Inc.$1K
  • Arthrex$768
  • Novastep Inc.$442
  • plus $953 from 15 others

What the payments were for

  • Travel & lodging$5,22641%
  • Food & beverage$3,05724%
  • Education$4,35134%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,634 in reported general payments places this provider in the 90th percentile of 122 foot and ankle surgery providers in Massachusetts.

See all foot and ankle surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$121,833
Medicare patients
438
Services billed
1,795

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam30$62

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in North Easton

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →